NCT05128032 (PEDIR) is a NA clinical trial of Standard microcatheter in Liver Cancer, sponsored by Massachusetts General Hospital.

Who is sponsoring NCT05128032?

NCT05128032 is sponsored by Massachusetts General Hospital.

What drugs are being tested in NCT05128032?

Interventions in NCT05128032: Standard microcatheter, PEDD device.

What condition does NCT05128032 study?

NCT05128032 studies Liver Cancer, Hepatocellular Carcinoma, Metastatic Colorectal Cancer.

Is NCT05128032 still recruiting?

NCT05128032 is currently active, enrolled. Last updated 19 March 2026.

Last reviewed 2026-03-19 · How we verify

NCT05128032: PEDIR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pressure-enabled Delivery in Radioembolization (TriNav Study)

Active, enrolled NA Last updated 19 March 2026

What this trial tests

NA trial testing Standard microcatheter in Liver Cancer in 20 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 March 2022

Primary endpoint
1 June 2026

1 September 2026

Quick facts

Lead sponsor	Massachusetts General Hospital
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	20
Start date	1 March 2022
Primary completion	1 June 2026
Estimated completion	1 September 2026
Sites	2 locations across United States

Drugs / interventions tested

Standard microcatheter
PEDD device

Conditions studied

Liver Cancer — all drugs for Liver Cancer →
Hepatocellular Carcinoma — all drugs for Hepatocellular Carcinoma →
Metastatic Colorectal Cancer — all drugs for Metastatic Colorectal Cancer →

Sponsor

Massachusetts General Hospital

Who can join

18 and older, any sex, with Liver Cancer or Hepatocellular Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to determine if the type of catheter used in the mapping procedure prior to radioembolization improves the delivery of radioactivity to tumor(s) in participants with liver cancer. The name of the devices involved in this study are: * Pressure Enabled Drug Delivery (PEDD)/TriNav Infusion System * Standard 2.4F microcatheter, not otherwise specified

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Liver Cancer

Currently open trials in the same condition.

NCT07295275 — Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection · recruiting
NCT07410494 — Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors · Phase 1, PHASE2 · recruiting
NCT07295340 — Diagnostic Accuracy of Folate-Targeted NIR-II Carbon Dots for Ex Vivo HCC Detection · recruiting
NCT07504367 — Large Language Models Assist in Tumor MDT · NA · recruiting
NCT07447050 — Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial · Phase 2 · recruiting

Other Massachusetts General Hospital trials

Trials by the same sponsor.

NCT03585946 — Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis · withdrawn
NCT07214831 — A Feasibility and Acceptability Study of a Large Language Model-based Chatbot for Brief Alcohol Intervention Among Emerg · NA · not yet recruiting
NCT06686901 — A Randomized Controlled Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior · NA · not yet recruiting
NCT05854212 — Behavioral Economics to Implement Nutrition Ranking in Food Pantries · NA · not yet recruiting
NCT07323446 — The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05128032 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Massachusetts General Hospital
Last refreshed: 19 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05128032.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing